Cancer Drug Therapy Market - Global Outlook and Forecast 2022-2028
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report contains market size and forecasts of Cancer Drug Therapy in global, including the following market information:
Global Cancer Drug Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Drug Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Drug Therapy companies in 2021 (%)
The global Cancer Drug Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Drug Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Type, 2021 (%)
Global Cancer Drug Therapy Market Segment Percentages, by Application, 2021 (%)
Global Cancer Drug Therapy Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Cancer Drug Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Drug Therapy revenues share in global market, 2021 (%)
Key companies Cancer Drug Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Drug Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report contains market size and forecasts of Cancer Drug Therapy in global, including the following market information:
Global Cancer Drug Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Drug Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Drug Therapy companies in 2021 (%)
The global Cancer Drug Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Drug Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Type, 2021 (%)
- Targeted Therapy
- Chemotherapy
- Immunotherapy
Global Cancer Drug Therapy Market Segment Percentages, by Application, 2021 (%)
- Angiogenesis Inhibitors
- mTOR Inhibitors
- Monoclonal Antibodies
- Cytokine Immunotherapy (IL-2)
Global Cancer Drug Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Cancer Drug Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Drug Therapy revenues share in global market, 2021 (%)
Key companies Cancer Drug Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Drug Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen / Allergan
- Argos Therapeutics
- AstraZeneca
- Aveo Pharmaceuticals
- Bayer
- Exelixis
- Incyte
- Merck
- Roche
- Bristol-Myers Squibb
- Eisai
- Exelixis
- Genentech (Roche)
- Novartis
- Pfizer
- Prometheus Labs
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cancer Drug Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Drug Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CANCER DRUG THERAPY OVERALL MARKET SIZE
2.1 Global Cancer Drug Therapy Market Size: 2021 VS 2028
2.2 Global Cancer Drug Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cancer Drug Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Cancer Drug Therapy Players in Global Market
3.2 Top Global Cancer Drug Therapy Companies Ranked by Revenue
3.3 Global Cancer Drug Therapy Revenue by Companies
3.4 Global Cancer Drug Therapy Sales by Companies
3.5 Global Cancer Drug Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cancer Drug Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cancer Drug Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Drug Therapy Players in Global Market
3.8.1 List of Global Tier 1 Cancer Drug Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Cancer Drug Therapy Market Size Markets, 2021 & 2028
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.2 By Type - Global Cancer Drug Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Drug Therapy Revenue, 2017-2022
4.2.2 By Type - Global Cancer Drug Therapy Revenue, 2023-2028
4.2.3 By Type - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Cancer Drug Therapy Sales & Forecasts
4.3.1 By Type - Global Cancer Drug Therapy Sales, 2017-2022
4.3.2 By Type - Global Cancer Drug Therapy Sales, 2023-2028
4.3.3 By Type - Global Cancer Drug Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cancer Drug Therapy Market Size, 2021 & 2028
5.1.2 Angiogenesis Inhibitors
5.1.3 mTOR Inhibitors
5.1.4 Monoclonal Antibodies
5.1.5 Cytokine Immunotherapy (IL-2)
5.2 By Application - Global Cancer Drug Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Drug Therapy Revenue, 2017-2022
5.2.2 By Application - Global Cancer Drug Therapy Revenue, 2023-2028
5.2.3 By Application - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Cancer Drug Therapy Sales & Forecasts
5.3.1 By Application - Global Cancer Drug Therapy Sales, 2017-2022
5.3.2 By Application - Global Cancer Drug Therapy Sales, 2023-2028
5.3.3 By Application - Global Cancer Drug Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cancer Drug Therapy Market Size, 2021 & 2028
6.2 By Region - Global Cancer Drug Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Drug Therapy Revenue, 2017-2022
6.2.2 By Region - Global Cancer Drug Therapy Revenue, 2023-2028
6.2.3 By Region - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Cancer Drug Therapy Sales & Forecasts
6.3.1 By Region - Global Cancer Drug Therapy Sales, 2017-2022
6.3.2 By Region - Global Cancer Drug Therapy Sales, 2023-2028
6.3.3 By Region - Global Cancer Drug Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cancer Drug Therapy Revenue, 2017-2028
6.4.2 By Country - North America Cancer Drug Therapy Sales, 2017-2028
6.4.3 US Cancer Drug Therapy Market Size, 2017-2028
6.4.4 Canada Cancer Drug Therapy Market Size, 2017-2028
6.4.5 Mexico Cancer Drug Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cancer Drug Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Cancer Drug Therapy Sales, 2017-2028
6.5.3 Germany Cancer Drug Therapy Market Size, 2017-2028
6.5.4 France Cancer Drug Therapy Market Size, 2017-2028
6.5.5 U.K. Cancer Drug Therapy Market Size, 2017-2028
6.5.6 Italy Cancer Drug Therapy Market Size, 2017-2028
6.5.7 Russia Cancer Drug Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Cancer Drug Therapy Market Size, 2017-2028
6.5.9 Benelux Cancer Drug Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cancer Drug Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Cancer Drug Therapy Sales, 2017-2028
6.6.3 China Cancer Drug Therapy Market Size, 2017-2028
6.6.4 Japan Cancer Drug Therapy Market Size, 2017-2028
6.6.5 South Korea Cancer Drug Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Cancer Drug Therapy Market Size, 2017-2028
6.6.7 India Cancer Drug Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cancer Drug Therapy Revenue, 2017-2028
6.7.2 By Country - South America Cancer Drug Therapy Sales, 2017-2028
6.7.3 Brazil Cancer Drug Therapy Market Size, 2017-2028
6.7.4 Argentina Cancer Drug Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Drug Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cancer Drug Therapy Sales, 2017-2028
6.8.3 Turkey Cancer Drug Therapy Market Size, 2017-2028
6.8.4 Israel Cancer Drug Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Cancer Drug Therapy Market Size, 2017-2028
6.8.6 UAE Cancer Drug Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Corporate Summary
7.1.2 Amgen / Allergan Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Major Product Offerings
7.1.4 Amgen / Allergan Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Amgen / Allergan Key News
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporate Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Major Product Offerings
7.2.4 Argos Therapeutics Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Argos Therapeutics Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Major Product Offerings
7.3.4 AstraZeneca Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Corporate Summary
7.4.2 Aveo Pharmaceuticals Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Major Product Offerings
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Aveo Pharmaceuticals Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cancer Drug Therapy Major Product Offerings
7.5.4 Bayer Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Exelixis
7.6.1 Exelixis Corporate Summary
7.6.2 Exelixis Business Overview
7.6.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.6.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Exelixis Key News
7.7 Incyte
7.7.1 Incyte Corporate Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Cancer Drug Therapy Major Product Offerings
7.7.4 Incyte Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Incyte Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Cancer Drug Therapy Major Product Offerings
7.8.4 Merck Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Roche
7.9.1 Roche Corporate Summary
7.9.2 Roche Business Overview
7.9.3 Roche Cancer Drug Therapy Major Product Offerings
7.9.4 Roche Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Roche Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Major Product Offerings
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Bristol-Myers Squibb Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Cancer Drug Therapy Business Overview
7.11.3 Eisai Cancer Drug Therapy Major Product Offerings
7.11.4 Eisai Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Eisai Key News
7.12 Exelixis
7.12.1 Exelixis Corporate Summary
7.12.2 Exelixis Cancer Drug Therapy Business Overview
7.12.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.12.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Exelixis Key News
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Corporate Summary
7.13.2 Genentech (Roche) Cancer Drug Therapy Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Major Product Offerings
7.13.4 Genentech (Roche) Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Genentech (Roche) Key News
7.14 Novartis
7.14.1 Novartis Corporate Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Cancer Drug Therapy Major Product Offerings
7.14.4 Novartis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Novartis Key News
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Cancer Drug Therapy Major Product Offerings
7.15.4 Pfizer Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Pfizer Key News
7.16 Prometheus Labs
7.16.1 Prometheus Labs Corporate Summary
7.16.2 Prometheus Labs Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Major Product Offerings
7.16.4 Prometheus Labs Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Prometheus Labs Key News
8 GLOBAL CANCER DRUG THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Cancer Drug Therapy Production Capacity, 2017-2028
8.2 Cancer Drug Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Drug Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CANCER DRUG THERAPY SUPPLY CHAIN ANALYSIS
10.1 Cancer Drug Therapy Industry Value Chain
10.2 Cancer Drug Therapy Upstream Market
10.3 Cancer Drug Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Drug Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Cancer Drug Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Drug Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CANCER DRUG THERAPY OVERALL MARKET SIZE
2.1 Global Cancer Drug Therapy Market Size: 2021 VS 2028
2.2 Global Cancer Drug Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cancer Drug Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Cancer Drug Therapy Players in Global Market
3.2 Top Global Cancer Drug Therapy Companies Ranked by Revenue
3.3 Global Cancer Drug Therapy Revenue by Companies
3.4 Global Cancer Drug Therapy Sales by Companies
3.5 Global Cancer Drug Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cancer Drug Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cancer Drug Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Drug Therapy Players in Global Market
3.8.1 List of Global Tier 1 Cancer Drug Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Cancer Drug Therapy Market Size Markets, 2021 & 2028
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.2 By Type - Global Cancer Drug Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Drug Therapy Revenue, 2017-2022
4.2.2 By Type - Global Cancer Drug Therapy Revenue, 2023-2028
4.2.3 By Type - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Cancer Drug Therapy Sales & Forecasts
4.3.1 By Type - Global Cancer Drug Therapy Sales, 2017-2022
4.3.2 By Type - Global Cancer Drug Therapy Sales, 2023-2028
4.3.3 By Type - Global Cancer Drug Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cancer Drug Therapy Market Size, 2021 & 2028
5.1.2 Angiogenesis Inhibitors
5.1.3 mTOR Inhibitors
5.1.4 Monoclonal Antibodies
5.1.5 Cytokine Immunotherapy (IL-2)
5.2 By Application - Global Cancer Drug Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Drug Therapy Revenue, 2017-2022
5.2.2 By Application - Global Cancer Drug Therapy Revenue, 2023-2028
5.2.3 By Application - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Cancer Drug Therapy Sales & Forecasts
5.3.1 By Application - Global Cancer Drug Therapy Sales, 2017-2022
5.3.2 By Application - Global Cancer Drug Therapy Sales, 2023-2028
5.3.3 By Application - Global Cancer Drug Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cancer Drug Therapy Market Size, 2021 & 2028
6.2 By Region - Global Cancer Drug Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Drug Therapy Revenue, 2017-2022
6.2.2 By Region - Global Cancer Drug Therapy Revenue, 2023-2028
6.2.3 By Region - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Cancer Drug Therapy Sales & Forecasts
6.3.1 By Region - Global Cancer Drug Therapy Sales, 2017-2022
6.3.2 By Region - Global Cancer Drug Therapy Sales, 2023-2028
6.3.3 By Region - Global Cancer Drug Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cancer Drug Therapy Revenue, 2017-2028
6.4.2 By Country - North America Cancer Drug Therapy Sales, 2017-2028
6.4.3 US Cancer Drug Therapy Market Size, 2017-2028
6.4.4 Canada Cancer Drug Therapy Market Size, 2017-2028
6.4.5 Mexico Cancer Drug Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cancer Drug Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Cancer Drug Therapy Sales, 2017-2028
6.5.3 Germany Cancer Drug Therapy Market Size, 2017-2028
6.5.4 France Cancer Drug Therapy Market Size, 2017-2028
6.5.5 U.K. Cancer Drug Therapy Market Size, 2017-2028
6.5.6 Italy Cancer Drug Therapy Market Size, 2017-2028
6.5.7 Russia Cancer Drug Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Cancer Drug Therapy Market Size, 2017-2028
6.5.9 Benelux Cancer Drug Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cancer Drug Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Cancer Drug Therapy Sales, 2017-2028
6.6.3 China Cancer Drug Therapy Market Size, 2017-2028
6.6.4 Japan Cancer Drug Therapy Market Size, 2017-2028
6.6.5 South Korea Cancer Drug Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Cancer Drug Therapy Market Size, 2017-2028
6.6.7 India Cancer Drug Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cancer Drug Therapy Revenue, 2017-2028
6.7.2 By Country - South America Cancer Drug Therapy Sales, 2017-2028
6.7.3 Brazil Cancer Drug Therapy Market Size, 2017-2028
6.7.4 Argentina Cancer Drug Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Drug Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cancer Drug Therapy Sales, 2017-2028
6.8.3 Turkey Cancer Drug Therapy Market Size, 2017-2028
6.8.4 Israel Cancer Drug Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Cancer Drug Therapy Market Size, 2017-2028
6.8.6 UAE Cancer Drug Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Corporate Summary
7.1.2 Amgen / Allergan Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Major Product Offerings
7.1.4 Amgen / Allergan Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Amgen / Allergan Key News
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporate Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Major Product Offerings
7.2.4 Argos Therapeutics Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Argos Therapeutics Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Major Product Offerings
7.3.4 AstraZeneca Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Corporate Summary
7.4.2 Aveo Pharmaceuticals Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Major Product Offerings
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Aveo Pharmaceuticals Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cancer Drug Therapy Major Product Offerings
7.5.4 Bayer Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Exelixis
7.6.1 Exelixis Corporate Summary
7.6.2 Exelixis Business Overview
7.6.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.6.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Exelixis Key News
7.7 Incyte
7.7.1 Incyte Corporate Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Cancer Drug Therapy Major Product Offerings
7.7.4 Incyte Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Incyte Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Cancer Drug Therapy Major Product Offerings
7.8.4 Merck Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Roche
7.9.1 Roche Corporate Summary
7.9.2 Roche Business Overview
7.9.3 Roche Cancer Drug Therapy Major Product Offerings
7.9.4 Roche Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Roche Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Major Product Offerings
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Bristol-Myers Squibb Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Cancer Drug Therapy Business Overview
7.11.3 Eisai Cancer Drug Therapy Major Product Offerings
7.11.4 Eisai Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Eisai Key News
7.12 Exelixis
7.12.1 Exelixis Corporate Summary
7.12.2 Exelixis Cancer Drug Therapy Business Overview
7.12.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.12.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Exelixis Key News
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Corporate Summary
7.13.2 Genentech (Roche) Cancer Drug Therapy Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Major Product Offerings
7.13.4 Genentech (Roche) Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Genentech (Roche) Key News
7.14 Novartis
7.14.1 Novartis Corporate Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Cancer Drug Therapy Major Product Offerings
7.14.4 Novartis Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Novartis Key News
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Cancer Drug Therapy Major Product Offerings
7.15.4 Pfizer Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Pfizer Key News
7.16 Prometheus Labs
7.16.1 Prometheus Labs Corporate Summary
7.16.2 Prometheus Labs Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Major Product Offerings
7.16.4 Prometheus Labs Cancer Drug Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Prometheus Labs Key News
8 GLOBAL CANCER DRUG THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Cancer Drug Therapy Production Capacity, 2017-2028
8.2 Cancer Drug Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Drug Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CANCER DRUG THERAPY SUPPLY CHAIN ANALYSIS
10.1 Cancer Drug Therapy Industry Value Chain
10.2 Cancer Drug Therapy Upstream Market
10.3 Cancer Drug Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Drug Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Cancer Drug Therapy in Global Market
Table 2. Top Cancer Drug Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cancer Drug Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cancer Drug Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Cancer Drug Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Cancer Drug Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cancer Drug Therapy Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Cancer Drug Therapy Product Type
Table 9. List of Global Tier 1 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 46. Amgen / Allergan Corporate Summary
Table 47. Amgen / Allergan Cancer Drug Therapy Product Offerings
Table 48. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Argos Therapeutics Corporate Summary
Table 50. Argos Therapeutics Cancer Drug Therapy Product Offerings
Table 51. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Cancer Drug Therapy Product Offerings
Table 54. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Aveo Pharmaceuticals Corporate Summary
Table 56. Aveo Pharmaceuticals Cancer Drug Therapy Product Offerings
Table 57. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Cancer Drug Therapy Product Offerings
Table 60. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Exelixis Corporate Summary
Table 62. Exelixis Cancer Drug Therapy Product Offerings
Table 63. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Incyte Corporate Summary
Table 65. Incyte Cancer Drug Therapy Product Offerings
Table 66. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Cancer Drug Therapy Product Offerings
Table 69. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Roche Corporate Summary
Table 71. Roche Cancer Drug Therapy Product Offerings
Table 72. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Bristol-Myers Squibb Corporate Summary
Table 74. Bristol-Myers Squibb Cancer Drug Therapy Product Offerings
Table 75. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Eisai Corporate Summary
Table 77. Eisai Cancer Drug Therapy Product Offerings
Table 78. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Exelixis Corporate Summary
Table 80. Exelixis Cancer Drug Therapy Product Offerings
Table 81. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Genentech (Roche) Corporate Summary
Table 83. Genentech (Roche) Cancer Drug Therapy Product Offerings
Table 84. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Novartis Corporate Summary
Table 86. Novartis Cancer Drug Therapy Product Offerings
Table 87. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Pfizer Corporate Summary
Table 89. Pfizer Cancer Drug Therapy Product Offerings
Table 90. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Prometheus Labs Corporate Summary
Table 92. Prometheus Labs Cancer Drug Therapy Product Offerings
Table 93. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Cancer Drug Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 95. Global Cancer Drug Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Cancer Drug Therapy Production by Region, 2017-2022 (K Units)
Table 97. Global Cancer Drug Therapy Production by Region, 2023-2028 (K Units)
Table 98. Cancer Drug Therapy Market Opportunities & Trends in Global Market
Table 99. Cancer Drug Therapy Market Drivers in Global Market
Table 100. Cancer Drug Therapy Market Restraints in Global Market
Table 101. Cancer Drug Therapy Raw Materials
Table 102. Cancer Drug Therapy Raw Materials Suppliers in Global Market
Table 103. Typical Cancer Drug Therapy Downstream
Table 104. Cancer Drug Therapy Downstream Clients in Global Market
Table 105. Cancer Drug Therapy Distributors and Sales Agents in Global Market
Table 1. Key Players of Cancer Drug Therapy in Global Market
Table 2. Top Cancer Drug Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cancer Drug Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cancer Drug Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Cancer Drug Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Cancer Drug Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cancer Drug Therapy Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Cancer Drug Therapy Product Type
Table 9. List of Global Tier 1 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Cancer Drug Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cancer Drug Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Cancer Drug Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2023-2028
Table 46. Amgen / Allergan Corporate Summary
Table 47. Amgen / Allergan Cancer Drug Therapy Product Offerings
Table 48. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Argos Therapeutics Corporate Summary
Table 50. Argos Therapeutics Cancer Drug Therapy Product Offerings
Table 51. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Cancer Drug Therapy Product Offerings
Table 54. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Aveo Pharmaceuticals Corporate Summary
Table 56. Aveo Pharmaceuticals Cancer Drug Therapy Product Offerings
Table 57. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Cancer Drug Therapy Product Offerings
Table 60. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Exelixis Corporate Summary
Table 62. Exelixis Cancer Drug Therapy Product Offerings
Table 63. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Incyte Corporate Summary
Table 65. Incyte Cancer Drug Therapy Product Offerings
Table 66. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Cancer Drug Therapy Product Offerings
Table 69. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Roche Corporate Summary
Table 71. Roche Cancer Drug Therapy Product Offerings
Table 72. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Bristol-Myers Squibb Corporate Summary
Table 74. Bristol-Myers Squibb Cancer Drug Therapy Product Offerings
Table 75. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Eisai Corporate Summary
Table 77. Eisai Cancer Drug Therapy Product Offerings
Table 78. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Exelixis Corporate Summary
Table 80. Exelixis Cancer Drug Therapy Product Offerings
Table 81. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Genentech (Roche) Corporate Summary
Table 83. Genentech (Roche) Cancer Drug Therapy Product Offerings
Table 84. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Novartis Corporate Summary
Table 86. Novartis Cancer Drug Therapy Product Offerings
Table 87. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Pfizer Corporate Summary
Table 89. Pfizer Cancer Drug Therapy Product Offerings
Table 90. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Prometheus Labs Corporate Summary
Table 92. Prometheus Labs Cancer Drug Therapy Product Offerings
Table 93. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Cancer Drug Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 95. Global Cancer Drug Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Cancer Drug Therapy Production by Region, 2017-2022 (K Units)
Table 97. Global Cancer Drug Therapy Production by Region, 2023-2028 (K Units)
Table 98. Cancer Drug Therapy Market Opportunities & Trends in Global Market
Table 99. Cancer Drug Therapy Market Drivers in Global Market
Table 100. Cancer Drug Therapy Market Restraints in Global Market
Table 101. Cancer Drug Therapy Raw Materials
Table 102. Cancer Drug Therapy Raw Materials Suppliers in Global Market
Table 103. Typical Cancer Drug Therapy Downstream
Table 104. Cancer Drug Therapy Downstream Clients in Global Market
Table 105. Cancer Drug Therapy Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Cancer Drug Therapy Segment by Type
Figure 2. Cancer Drug Therapy Segment by Application
Figure 3. Global Cancer Drug Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Drug Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Drug Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Cancer Drug Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Drug Therapy Revenue in 2021
Figure 9. By Type - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cancer Drug Therapy Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cancer Drug Therapy Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 19. US Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 24. Germany Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 33. China Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cancer Drug Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cancer Drug Therapy by Region, 2020 VS 2027
Figure 50. Cancer Drug Therapy Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Cancer Drug Therapy Segment by Type
Figure 2. Cancer Drug Therapy Segment by Application
Figure 3. Global Cancer Drug Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Drug Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Drug Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Cancer Drug Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Drug Therapy Revenue in 2021
Figure 9. By Type - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cancer Drug Therapy Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cancer Drug Therapy Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 19. US Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 24. Germany Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 33. China Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cancer Drug Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cancer Drug Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cancer Drug Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cancer Drug Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cancer Drug Therapy by Region, 2020 VS 2027
Figure 50. Cancer Drug Therapy Industry Value Chain
Figure 51. Marketing Channels
